http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
XRP News: XRPTurbo's Presale Draws Major Investors From $ADA, $ICP & $SOL As The $XRT Presale Surpasses Softcap
-
XRP News: XRPTurbo's Presale Draws Major Investors From $ADA, $ICP & $SOL As The $XRT Presale Surpasses Softcap
-
DeFi Technologies Provides Monthly Corporate Update: Valour Reports C$1.07 Billion (US$750 Million) in AUM, and Monthly Net Inflows of C$16.4 Million (US$11.4 Million) in February 2025, Among Other Ke
-
Tinley's Announces Sales and Distribution Expansion and Name Change to Beckett's Inc.
-
Silver47 Commences Trading on OTC Markets Under the Ticker Symbol OTCQB: AAGAF
-
CDN Maverick Expands Poncheville Prospects Using AI-driven Mineral Targeting, Announces Peek VP Exploration
-
Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy
-
Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting
-
Ionis Pharmaceuticals (IONS) Announces WAINZUA approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy
-
Mineralys Therapeutics (MLYS) Announces Positive Topline Results from Launch-HTN and Advance-HTN Trials of Lorundrostat
-
West Point Gold Announces Mark Reischman Joins as Technical Advisor
-
ZYUS Life Sciences Corporation Announces Close of Unsecured Loan and Amendment to Prior Unsecured Loans
-
Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension
-
Intelsat and MaxIQ Space Expand STEM Learning to Educators in Multiple African Countries
-
WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy
-
Intelsat and MaxIQ Space Expand STEM Learning to Educators in Multiple African Countries
-
Packline Materials Handling Announce Production Of Their New Powered Clamp Attachment For Handling Narrow Rolls Of Film Or Foil In The Food And Pharmaceutical Industries
-
Meridian Mining’s Cabaçal Pre-Feasibility Study Delivers USD 984 million NPV5 & 61.2% IRR (After-Tax), and Annual Average Production 141,000 AuEq Ounces
-
FRONTERA ANNOUNCES FOURTH QUARTER AND YEAR END 2024 RESULTS, YEAR-END RESERVES AND OPERATIONAL UPDATE
-
Trevi Therapeutics (TRVI) Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio
-
Pudu Robotics' PUDU T300 Achieves CE-MD and CE-RED Certifications, Empowering Global Smart Manufacturing with International Safety Standards
-
Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough
-
Analog Devices Introduces Expanded CodeFusion Studio™ Solution to Accelerate Product Development and Ensure Data Security
-
Polish PM Tusk cautions 'friends' against arrogance after Starlink spat
-
Tech Mahindra Strengthens its U.S. Operations with a New Americas Headquarters in Plano, Texas
-
Ant Insurance Uses AI to Help Partner Insurers Process 7.25 Million Health Claims in 2024, Up 55% YoY
-
WikiEXPO Hong Kong 2025: Asia's Premier Fintech Event Is Coming Soon
-
AB is Now Listed on Hotcoin and Set to Launch on Gate, BitMart, Lbank, and Biconomy
-
Sun Pharma to Acquire Checkpoint Therapeutics
-
Sun Pharma to Acquire Checkpoint Therapeutics
-
Bitdeer Completes Testing of its Latest SEAL03 Bitcoin Mining Chip
-
National Police Federation Congratulates Mark Carney; Looks Forward to Building on Government’s Public Safety Improvements
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IAS
-
ROSEN, A LEADING AND RANKED FIRM, Encourages Skyworks Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SWKS
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Rocket Lab USA, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RKLB
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages FMC Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - FMC
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Elastic N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ESTC
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ICON plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - ICLR
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Edison International Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - EIX
-
Trevi Therapeutics to Host Conference Call and Webcast on March 10th to Share Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough
-
Early Investors Rush to Hexydog, Best Crypto Presales Opportunity of March
-
ROSEN, A LEADING AND RANKED FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
-
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Newmont Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - NEM
-
ROSEN, A LEADING LAW FIRM, Encourages Grocery Outlet Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GO
-
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Quantum Computing Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QUBT
-
ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
-
ROSEN, A LONGSTANDING FIRM, Encourages Alarum Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALAR
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Venture Global, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VG

